Global Organ Transplant Immunosuppressant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 138043
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Immunosuppressants are a class of drugs that suppress the immune response through various mechanisms. In organ transplantation, immunosuppressants are used to prevent the body from either recognition or attacking the foreign organ via various immune responses. They should only be used under the supervision of appropriately trained and experienced staff.

According to our latest study, the global Organ Transplant Immunosuppressant market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In China, Organ Transplant Immunosuppressant key players include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, etc.

This report is a detailed and comprehensive analysis for global Organ Transplant Immunosuppressant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Organ Transplant Immunosuppressant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Organ Transplant Immunosuppressant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Organ Transplant Immunosuppressant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Organ Transplant Immunosuppressant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Organ Transplant Immunosuppressant

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Organ Transplant Immunosuppressant market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis and Catalent Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Organ Transplant Immunosuppressant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Tacrolimus

Mycophenolate Mofetil

Cyclosporin

Others

Market segment by Application

Liver Transplant

Kidney Transplant

Heart Transplant

Other Organ Transplant

Major players covered

Roche

Astellas Pharma Inc.

Huadong Pharmaceutical

Novartis

Catalent Pharma

Cinkate Corporation

Cilag

Genzyme

Changzhou Pharm

North China Pharmaceutical Group Corporation

SL PHARM

Livzon Pharmaceutical Group Inc.,

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Organ Transplant Immunosuppressant product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Organ Transplant Immunosuppressant, with price, sales, revenue and global market share of Organ Transplant Immunosuppressant from 2018 to 2023.

Chapter 3, the Organ Transplant Immunosuppressant competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Organ Transplant Immunosuppressant breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Organ Transplant Immunosuppressant market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Organ Transplant Immunosuppressant.

Chapter 14 and 15, to describe Organ Transplant Immunosuppressant sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Organ Transplant Immunosuppressant

1.2 Market Estimation Caveats and Base Year

1.3 Market Analysis by Type

1.3.1 Overview: Global Organ Transplant Immunosuppressant Consumption Value by Type: 2018 Versus 2022 Versus 2029

1.3.2 Tacrolimus

1.3.3 Mycophenolate Mofetil

1.3.4 Cyclosporin

1.3.5 Others

1.4 Market Analysis by Application

1.4.1 Overview: Global Organ Transplant Immunosuppressant Consumption Value by Application: 2018 Versus 2022 Versus 2029

1.4.2 Liver Transplant

1.4.3 Kidney Transplant

1.4.4 Heart Transplant

1.4.5 Other Organ Transplant

1.5 Global Organ Transplant Immunosuppressant Market Size & Forecast

1.5.1 Global Organ Transplant Immunosuppressant Consumption Value (2018 & 2022 & 2029)

1.5.2 Global Organ Transplant Immunosuppressant Sales Quantity (2018-2029)

1.5.3 Global Organ Transplant Immunosuppressant Average Price (2018-2029)

2 Manufacturers Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Organ Transplant Immunosuppressant Product and Services

2.1.4 Roche Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Roche Recent Developments/Updates

2.2 Astellas Pharma Inc.

2.2.1 Astellas Pharma Inc. Details

2.2.2 Astellas Pharma Inc. Major Business

2.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Product and Services

2.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Astellas Pharma Inc. Recent Developments/Updates

2.3 Huadong Pharmaceutical

2.3.1 Huadong Pharmaceutical Details

2.3.2 Huadong Pharmaceutical Major Business

2.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Product and Services

2.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Huadong Pharmaceutical Recent Developments/Updates

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Organ Transplant Immunosuppressant Product and Services

2.4.4 Novartis Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Novartis Recent Developments/Updates

2.5 Catalent Pharma

2.5.1 Catalent Pharma Details

2.5.2 Catalent Pharma Major Business

2.5.3 Catalent Pharma Organ Transplant Immunosuppressant Product and Services

2.5.4 Catalent Pharma Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Catalent Pharma Recent Developments/Updates

2.6 Cinkate Corporation

2.6.1 Cinkate Corporation Details

2.6.2 Cinkate Corporation Major Business

2.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Product and Services

2.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Cinkate Corporation Recent Developments/Updates

2.7 Cilag

2.7.1 Cilag Details

2.7.2 Cilag Major Business

2.7.3 Cilag Organ Transplant Immunosuppressant Product and Services

2.7.4 Cilag Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Cilag Recent Developments/Updates

2.8 Genzyme

2.8.1 Genzyme Details

2.8.2 Genzyme Major Business

2.8.3 Genzyme Organ Transplant Immunosuppressant Product and Services

2.8.4 Genzyme Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Genzyme Recent Developments/Updates

2.9 Changzhou Pharm

2.9.1 Changzhou Pharm Details

2.9.2 Changzhou Pharm Major Business

2.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Product and Services

2.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Changzhou Pharm Recent Developments/Updates

2.10 North China Pharmaceutical Group Corporation

2.10.1 North China Pharmaceutical Group Corporation Details

2.10.2 North China Pharmaceutical Group Corporation Major Business

2.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product and Services

2.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 North China Pharmaceutical Group Corporation Recent Developments/Updates

2.11 SL PHARM

2.11.1 SL PHARM Details

2.11.2 SL PHARM Major Business

2.11.3 SL PHARM Organ Transplant Immunosuppressant Product and Services

2.11.4 SL PHARM Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 SL PHARM Recent Developments/Updates

2.12 Livzon Pharmaceutical Group Inc.,

2.12.1 Livzon Pharmaceutical Group Inc., Details

2.12.2 Livzon Pharmaceutical Group Inc., Major Business

2.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product and Services

2.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Livzon Pharmaceutical Group Inc., Recent Developments/Updates

3 Competitive Environment: Organ Transplant Immunosuppressant by Manufacturer

3.1 Global Organ Transplant Immunosuppressant Sales Quantity by Manufacturer (2018-2023)

3.2 Global Organ Transplant Immunosuppressant Revenue by Manufacturer (2018-2023)

3.3 Global Organ Transplant Immunosuppressant Average Price by Manufacturer (2018-2023)

3.4 Market Share Analysis (2022)

3.4.1 Producer Shipments of Organ Transplant Immunosuppressant by Manufacturer Revenue ($MM) and Market Share (%): 2022

3.4.2 Top 3 Organ Transplant Immunosuppressant Manufacturer Market Share in 2022

3.4.2 Top 6 Organ Transplant Immunosuppressant Manufacturer Market Share in 2022

3.5 Organ Transplant Immunosuppressant Market: Overall Company Footprint Analysis

3.5.1 Organ Transplant Immunosuppressant Market: Region Footprint

3.5.2 Organ Transplant Immunosuppressant Market: Company Product Type Footprint

3.5.3 Organ Transplant Immunosuppressant Market: Company Product Application Footprint

3.6 New Market Entrants and Barriers to Market Entry

3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Organ Transplant Immunosuppressant Market Size by Region

4.1.1 Global Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2029)

4.1.2 Global Organ Transplant Immunosuppressant Consumption Value by Region (2018-2029)

4.1.3 Global Organ Transplant Immunosuppressant Average Price by Region (2018-2029)

4.2 North America Organ Transplant Immunosuppressant Consumption Value (2018-2029)

4.3 Europe Organ Transplant Immunosuppressant Consumption Value (2018-2029)

4.4 Asia-Pacific Organ Transplant Immunosuppressant Consumption Value (2018-2029)

4.5 South America Organ Transplant Immunosuppressant Consumption Value (2018-2029)

4.6 Middle East and Africa Organ Transplant Immunosuppressant Consumption Value (2018-2029)

5 Market Segment by Type

5.1 Global Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

5.2 Global Organ Transplant Immunosuppressant Consumption Value by Type (2018-2029)

5.3 Global Organ Transplant Immunosuppressant Average Price by Type (2018-2029)

6 Market Segment by Application

6.1 Global Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

6.2 Global Organ Transplant Immunosuppressant Consumption Value by Application (2018-2029)

6.3 Global Organ Transplant Immunosuppressant Average Price by Application (2018-2029)

7 North America

7.1 North America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

7.2 North America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

7.3 North America Organ Transplant Immunosuppressant Market Size by Country

7.3.1 North America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)

7.3.2 North America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)

7.3.3 United States Market Size and Forecast (2018-2029)

7.3.4 Canada Market Size and Forecast (2018-2029)

7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

8.1 Europe Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

8.2 Europe Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

8.3 Europe Organ Transplant Immunosuppressant Market Size by Country

8.3.1 Europe Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)

8.3.2 Europe Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)

8.3.3 Germany Market Size and Forecast (2018-2029)

8.3.4 France Market Size and Forecast (2018-2029)

8.3.5 United Kingdom Market Size and Forecast (2018-2029)

8.3.6 Russia Market Size and Forecast (2018-2029)

8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

9.1 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

9.2 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

9.3 Asia-Pacific Organ Transplant Immunosuppressant Market Size by Region

9.3.1 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2029)

9.3.2 Asia-Pacific Organ Transplant Immunosuppressant Consumption Value by Region (2018-2029)

9.3.3 China Market Size and Forecast (2018-2029)

9.3.4 Japan Market Size and Forecast (2018-2029)

9.3.5 Korea Market Size and Forecast (2018-2029)

9.3.6 India Market Size and Forecast (2018-2029)

9.3.7 Southeast Asia Market Size and Forecast (2018-2029)

9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

10.1 South America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

10.2 South America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

10.3 South America Organ Transplant Immunosuppressant Market Size by Country

10.3.1 South America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)

10.3.2 South America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)

10.3.3 Brazil Market Size and Forecast (2018-2029)

10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

11.1 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)

11.2 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)

11.3 Middle East & Africa Organ Transplant Immunosuppressant Market Size by Country

11.3.1 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)

11.3.2 Middle East & Africa Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)

11.3.3 Turkey Market Size and Forecast (2018-2029)

11.3.4 Egypt Market Size and Forecast (2018-2029)

11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)

11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

12.1 Organ Transplant Immunosuppressant Market Drivers

12.2 Organ Transplant Immunosuppressant Market Restraints

12.3 Organ Transplant Immunosuppressant Trends Analysis

12.4 Porters Five Forces Analysis

12.4.1 Threat of New Entrants

12.4.2 Bargaining Power of Suppliers

12.4.3 Bargaining Power of Buyers

12.4.4 Threat of Substitutes

12.4.5 Competitive Rivalry

12.5 Influence of COVID-19 and Russia-Ukraine War

12.5.1 Influence of COVID-19

12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

13.1 Raw Material of Organ Transplant Immunosuppressant and Key Manufacturers

13.2 Manufacturing Costs Percentage of Organ Transplant Immunosuppressant

13.3 Organ Transplant Immunosuppressant Production Process

13.4 Organ Transplant Immunosuppressant Industrial Chain

14 Shipments by Distribution Channel

14.1 Sales Channel

14.1.1 Direct to End-User

14.1.2 Distributors

14.2 Organ Transplant Immunosuppressant Typical Distributors

14.3 Organ Transplant Immunosuppressant Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Research Process and Data Source

16.3 Disclaimer

List of Tables

Table 1. Global Organ Transplant Immunosuppressant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Organ Transplant Immunosuppressant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Roche Basic Information, Manufacturing Base and Competitors

Table 4. Roche Major Business

Table 5. Roche Organ Transplant Immunosuppressant Product and Services

Table 6. Roche Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 7. Roche Recent Developments/Updates

Table 8. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table 9. Astellas Pharma Inc. Major Business

Table 10. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product and Services

Table 11. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 12. Astellas Pharma Inc. Recent Developments/Updates

Table 13. Huadong Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 14. Huadong Pharmaceutical Major Business

Table 15. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product and Services

Table 16. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 17. Huadong Pharmaceutical Recent Developments/Updates

Table 18. Novartis Basic Information, Manufacturing Base and Competitors

Table 19. Novartis Major Business

Table 20. Novartis Organ Transplant Immunosuppressant Product and Services

Table 21. Novartis Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 22. Novartis Recent Developments/Updates

Table 23. Catalent Pharma Basic Information, Manufacturing Base and Competitors

Table 24. Catalent Pharma Major Business

Table 25. Catalent Pharma Organ Transplant Immunosuppressant Product and Services

Table 26. Catalent Pharma Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 27. Catalent Pharma Recent Developments/Updates

Table 28. Cinkate Corporation Basic Information, Manufacturing Base and Competitors

Table 29. Cinkate Corporation Major Business

Table 30. Cinkate Corporation Organ Transplant Immunosuppressant Product and Services

Table 31. Cinkate Corporation Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 32. Cinkate Corporation Recent Developments/Updates

Table 33. Cilag Basic Information, Manufacturing Base and Competitors

Table 34. Cilag Major Business

Table 35. Cilag Organ Transplant Immunosuppressant Product and Services

Table 36. Cilag Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 37. Cilag Recent Developments/Updates

Table 38. Genzyme Basic Information, Manufacturing Base and Competitors

Table 39. Genzyme Major Business

Table 40. Genzyme Organ Transplant Immunosuppressant Product and Services

Table 41. Genzyme Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 42. Genzyme Recent Developments/Updates

Table 43. Changzhou Pharm Basic Information, Manufacturing Base and Competitors

Table 44. Changzhou Pharm Major Business

Table 45. Changzhou Pharm Organ Transplant Immunosuppressant Product and Services

Table 46. Changzhou Pharm Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 47. Changzhou Pharm Recent Developments/Updates

Table 48. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors

Table 49. North China Pharmaceutical Group Corporation Major Business

Table 50. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product and Services

Table 51. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 52. North China Pharmaceutical Group Corporation Recent Developments/Updates

Table 53. SL PHARM Basic Information, Manufacturing Base and Competitors

Table 54. SL PHARM Major Business

Table 55. SL PHARM Organ Transplant Immunosuppressant Product and Services

Table 56. SL PHARM Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 57. SL PHARM Recent Developments/Updates

Table 58. Livzon Pharmaceutical Group Inc., Basic Information, Manufacturing Base and Competitors

Table 59. Livzon Pharmaceutical Group Inc., Major Business

Table 60. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product and Services

Table 61. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 62. Livzon Pharmaceutical Group Inc., Recent Developments/Updates

Table 63. Global Organ Transplant Immunosuppressant Sales Quantity by Manufacturer (2018-2023) & (K Units)

Table 64. Global Organ Transplant Immunosuppressant Revenue by Manufacturer (2018-2023) & (USD Million)

Table 65. Global Organ Transplant Immunosuppressant Average Price by Manufacturer (2018-2023) & (US$/Unit)

Table 66. Market Position of Manufacturers in Organ Transplant Immunosuppressant, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022

Table 67. Head Office and Organ Transplant Immunosuppressant Production Site of Key Manufacturer

Table 68. Organ Transplant Immunosuppressant Market: Company Product Type Footprint

Table 69. Organ Transplant Immunosuppressant Market: Company Product Application Footprint

Table 70. Organ Transplant Immunosuppressant New Market Entrants and Barriers to Market Entry

Table 71. Organ Transplant Immunosuppressant Mergers, Acquisition, Agreements, and Collaborations

Table 72. Global Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2023) & (K Units)

Table 73. Global Organ Transplant Immunosuppressant Sales Quantity by Region (2024-2029) & (K Units)

Table 74. Global Organ Transplant Immunosuppressant Consumption Value by Region (2018-2023) & (USD Million)

Table 75. Global Organ Transplant Immunosuppressant Consumption Value by Region (2024-2029) & (USD Million)

Table 76. Global Organ Transplant Immunosuppressant Average Price by Region (2018-2023) & (US$/Unit)

Table 77. Global Organ Transplant Immunosuppressant Average Price by Region (2024-2029) & (US$/Unit)

Table 78. Global Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 79. Global Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 80. Global Organ Transplant Immunosuppressant Consumption Value by Type (2018-2023) & (USD Million)

Table 81. Global Organ Transplant Immunosuppressant Consumption Value by Type (2024-2029) & (USD Million)

Table 82. Global Organ Transplant Immunosuppressant Average Price by Type (2018-2023) & (US$/Unit)

Table 83. Global Organ Transplant Immunosuppressant Average Price by Type (2024-2029) & (US$/Unit)

Table 84. Global Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 85. Global Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 86. Global Organ Transplant Immunosuppressant Consumption Value by Application (2018-2023) & (USD Million)

Table 87. Global Organ Transplant Immunosuppressant Consumption Value by Application (2024-2029) & (USD Million)

Table 88. Global Organ Transplant Immunosuppressant Average Price by Application (2018-2023) & (US$/Unit)

Table 89. Global Organ Transplant Immunosuppressant Average Price by Application (2024-2029) & (US$/Unit)

Table 90. North America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 91. North America Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 92. North America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 93. North America Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 94. North America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2023) & (K Units)

Table 95. North America Organ Transplant Immunosuppressant Sales Quantity by Country (2024-2029) & (K Units)

Table 96. North America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2023) & (USD Million)

Table 97. North America Organ Transplant Immunosuppressant Consumption Value by Country (2024-2029) & (USD Million)

Table 98. Europe Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 99. Europe Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 100. Europe Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 101. Europe Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 102. Europe Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2023) & (K Units)

Table 103. Europe Organ Transplant Immunosuppressant Sales Quantity by Country (2024-2029) & (K Units)

Table 104. Europe Organ Transplant Immunosuppressant Consumption Value by Country (2018-2023) & (USD Million)

Table 105. Europe Organ Transplant Immunosuppressant Consumption Value by Country (2024-2029) & (USD Million)

Table 106. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 107. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 108. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 109. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 110. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2023) & (K Units)

Table 111. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Region (2024-2029) & (K Units)

Table 112. Asia-Pacific Organ Transplant Immunosuppressant Consumption Value by Region (2018-2023) & (USD Million)

Table 113. Asia-Pacific Organ Transplant Immunosuppressant Consumption Value by Region (2024-2029) & (USD Million)

Table 114. South America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 115. South America Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 116. South America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 117. South America Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 118. South America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2023) & (K Units)

Table 119. South America Organ Transplant Immunosuppressant Sales Quantity by Country (2024-2029) & (K Units)

Table 120. South America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2023) & (USD Million)

Table 121. South America Organ Transplant Immunosuppressant Consumption Value by Country (2024-2029) & (USD Million)

Table 122. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2023) & (K Units)

Table 123. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Type (2024-2029) & (K Units)

Table 124. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2023) & (K Units)

Table 125. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Application (2024-2029) & (K Units)

Table 126. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2023) & (K Units)

Table 127. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Region (2024-2029) & (K Units)

Table 128. Middle East & Africa Organ Transplant Immunosuppressant Consumption Value by Region (2018-2023) & (USD Million)

Table 129. Middle East & Africa Organ Transplant Immunosuppressant Consumption Value by Region (2024-2029) & (USD Million)

Table 130. Organ Transplant Immunosuppressant Raw Material

Table 131. Key Manufacturers of Organ Transplant Immunosuppressant Raw Materials

Table 132. Organ Transplant Immunosuppressant Typical Distributors

Table 133. Organ Transplant Immunosuppressant Typical Customers

List of Figures

Figure 1. Organ Transplant Immunosuppressant Picture

Figure 2. Global Organ Transplant Immunosuppressant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Type in 2022

Figure 4. Tacrolimus Examples

Figure 5. Mycophenolate Mofetil Examples

Figure 6. Cyclosporin Examples

Figure 7. Others Examples

Figure 8. Global Organ Transplant Immunosuppressant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Figure 9. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Application in 2022

Figure 10. Liver Transplant Examples

Figure 11. Kidney Transplant Examples

Figure 12. Heart Transplant Examples

Figure 13. Other Organ Transplant Examples

Figure 14. Global Organ Transplant Immunosuppressant Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 15. Global Organ Transplant Immunosuppressant Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 16. Global Organ Transplant Immunosuppressant Sales Quantity (2018-2029) & (K Units)

Figure 17. Global Organ Transplant Immunosuppressant Average Price (2018-2029) & (US$/Unit)

Figure 18. Global Organ Transplant Immunosuppressant Sales Quantity Market Share by Manufacturer in 2022

Figure 19. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Manufacturer in 2022

Figure 20. Producer Shipments of Organ Transplant Immunosuppressant by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021

Figure 21. Top 3 Organ Transplant Immunosuppressant Manufacturer (Consumption Value) Market Share in 2022

Figure 22. Top 6 Organ Transplant Immunosuppressant Manufacturer (Consumption Value) Market Share in 2022

Figure 23. Global Organ Transplant Immunosuppressant Sales Quantity Market Share by Region (2018-2029)

Figure 24. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Region (2018-2029)

Figure 25. North America Organ Transplant Immunosuppressant Consumption Value (2018-2029) & (USD Million)

Figure 26. Europe Organ Transplant Immunosuppressant Consumption Value (2018-2029) & (USD Million)

Figure 27. Asia-Pacific Organ Transplant Immunosuppressant Consumption Value (2018-2029) & (USD Million)

Figure 28. South America Organ Transplant Immunosuppressant Consumption Value (2018-2029) & (USD Million)

Figure 29. Middle East & Africa Organ Transplant Immunosuppressant Consumption Value (2018-2029) & (USD Million)

Figure 30. Global Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 31. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Type (2018-2029)

Figure 32. Global Organ Transplant Immunosuppressant Average Price by Type (2018-2029) & (US$/Unit)

Figure 33. Global Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 34. Global Organ Transplant Immunosuppressant Consumption Value Market Share by Application (2018-2029)

Figure 35. Global Organ Transplant Immunosuppressant Average Price by Application (2018-2029) & (US$/Unit)

Figure 36. North America Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 37. North America Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 38. North America Organ Transplant Immunosuppressant Sales Quantity Market Share by Country (2018-2029)

Figure 39. North America Organ Transplant Immunosuppressant Consumption Value Market Share by Country (2018-2029)

Figure 40. United States Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 41. Canada Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 42. Mexico Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 43. Europe Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 44. Europe Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 45. Europe Organ Transplant Immunosuppressant Sales Quantity Market Share by Country (2018-2029)

Figure 46. Europe Organ Transplant Immunosuppressant Consumption Value Market Share by Country (2018-2029)

Figure 47. Germany Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 48. France Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 49. United Kingdom Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 50. Russia Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 51. Italy Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 52. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 53. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 54. Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity Market Share by Region (2018-2029)

Figure 55. Asia-Pacific Organ Transplant Immunosuppressant Consumption Value Market Share by Region (2018-2029)

Figure 56. China Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 57. Japan Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 58. Korea Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 59. India Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 60. Southeast Asia Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 61. Australia Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 62. South America Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 63. South America Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 64. South America Organ Transplant Immunosuppressant Sales Quantity Market Share by Country (2018-2029)

Figure 65. South America Organ Transplant Immunosuppressant Consumption Value Market Share by Country (2018-2029)

Figure 66. Brazil Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 67. Argentina Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 68. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity Market Share by Type (2018-2029)

Figure 69. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity Market Share by Application (2018-2029)

Figure 70. Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity Market Share by Region (2018-2029)

Figure 71. Middle East & Africa Organ Transplant Immunosuppressant Consumption Value Market Share by Region (2018-2029)

Figure 72. Turkey Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 73. Egypt Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 74. Saudi Arabia Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 75. South Africa Organ Transplant Immunosuppressant Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 76. Organ Transplant Immunosuppressant Market Drivers

Figure 77. Organ Transplant Immunosuppressant Market Restraints

Figure 78. Organ Transplant Immunosuppressant Market Trends

Figure 79. Porters Five Forces Analysis

Figure 80. Manufacturing Cost Structure Analysis of Organ Transplant Immunosuppressant in 2022

Figure 81. Manufacturing Process Analysis of Organ Transplant Immunosuppressant

Figure 82. Organ Transplant Immunosuppressant Industrial Chain

Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors

Figure 84. Direct Channel Pros & Cons

Figure 85. Indirect Channel Pros & Cons

Figure 86. Methodology

Figure 87. Research Process and Data Source